Patient info Search Menu

Childrens 3 Months Plus Simple Cough linctus, Infant sugar free Simple Cough linctus, Boots Cough syrup 3 Months Plus, Infant Simple Cough linctus 3 Months Plus – Summary of Product Characteristics (SmPC) for healthcare professionals

The Summary of Product Characteristics (SmPC) is written for healthcare professionals. Patients will find plain advice in the patient information leaflet.

Updated:
Key facts
Status:
General sale (GSL)
Medicine strength:
150 microlitre/ml
Contains active substance:
ATC code:

Summary of Product Characteristics (SmPC) - Childrens 3 Months Plus Simple Cough linctus, Infant sugar free Simple Cough linctus, Boots Cough syrup 3 Months Plus, Infant Simple Cough linctus 3 Months Plus

1 NAME OF THE MEDICINAL PRODUCT

Infant Simple Cough Linctus 3 Months Plus or Infant Sugar Free Simple Cough Linctus or Children's 3 Months Plus Simple Cough Linctus or Boots Cough Syrup 3 Months Plus.

2 QUALITATIVE AND QUANTITATIVE COMPOSITION

Active ingredient % v/v ml/5ml

Glycerol Ph Eur 15.0 0.75

3 PHARMACEUTICAL FORM

Syrup

4 CLINICAL PARTICULARS

4.1 Therapeutic indications

For the relief of dry tickly coughs.

4.2 Posology and Method of Administration

For oral administration.

Children 3 months - 1 year: one 5ml spoonful three to four times a day. Children 1 to 5 years: two 5ml spoonfuls three to four times a day. Children under 3 months: not recommended.

4.3 Contra-Indications

Hypersensitivity to any of the ingredients.

4.4 Special Warnings and Special Precautions for Use

Not recommended for children under 3 months.

If symptoms persist for more than 3 days consult your doctor. Keep all medicines out of the reach of children.

4.5 Interactions with other Medicinal Products and other Forms of Interaction

No clinically significant drug interactions.

4.6 Pregnancy and Lactation

The safety of this product during pregnancy and lactation has not been established but is not thought to constitute a hazard.

4.7 Effects on Ability to Drive and Use Machines

No adverse effects known.

4.8 Undesirable effects

Immune system disorder: hypersensitivity reactions, including anaphylaxis.

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard.

4.9 Overdose

Overdosage with this product may possibly cause diarrhoea. Treatment should be symptomatic.

5 PHARMACOLOGICAL PROPERTIES

5.1 Pharmacodynamic properties

Glycerin has demulcent properties and may possibly block sensory cough receptors in the respiratory tract.

5.2 Pharmacokinetic Properties

None stated.

5.3 Pre-clinical Safety Data

Not applicable.

6 PHARMACEUTICAL PARTICULARS

6.1 List of excipients

Maltitol liquid

Hydroxyethylcellulose

Sodium Benzoate

Citric Acid Monohydrate Sodium Citrate

Apple flavouring 5112OIE Purified Water

6.2 Incompatibilities

None stated.

6.3 Shelf-Life

36 months.

6.4 Special Precautions for Storage

Do not store above 25°C.

Keep tightly closed.

6.5 Nature and Content of Container

  1. 1)

    Bottle amber PET with polypropylene child resistant closure fitted with expanded polythene liner.

    Pack size: 150 ml, 100ml

  2. 2)

    Bottle amber glass with polypropylene child resistant closure fitted with an expanded polyethylene liner.

    Pack size 100, 125 or 150ml.

6.6 Instructions for Use, Handling and Disposal

Not applicable.

7 MARKETING AUTHORISATION HOLDER

The Boots Company PLC

1 Thane Road West

Nottingham

NG2 3AA

Trading as: BCM

8 MARKETING AUTHORISATION NUMBER(S)

PL 00014/0500

9 DATE OF FIRST AUTHORISATION/RENEWAL OF THE

AUTHORISATION

11/01/2007

10 DATE OF REVISION OF THE TEXT

14/07/2015

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk)

Last revision stated in the text: 14 July 2015

What the sections and the side effect frequencies mean: How to read a patient leaflet

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Childrens 3 Months Plus Simple Cough linctus, Infant sugar free Simple Cough linctus, Boots Cough syrup 3 Months Plus, Infant Simple Cough linctus 3 Months Plus

What these facts mean

Prescription needed?? No, general sale list medicine (GSL) – also sold outside pharmacies
Active substance? Glycerol
Strength? 150 microlitre/ml
Pharmaceutical form? Oral solution
How is it taken? Oral
Pack sizes 100 ml
Is it available?? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Drug group (ATC)?
  1. A Alimentary tract and metabolism drugs
    1. A06 Drugs for constipation
      1. A06A Drugs for constipation
        1. A06AX Other drugs for constipation
          1. A06AX01 glycerol
Marketing authorisation? PL 00014/0500
Codes? GTIN 5000167081428 · BNF 03090200

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 11.1.0 of 9 November 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.